TRANSFECTION REAGENTS AND EQUIPMENT MARKET IS PROJECTED TO GROW UP TO 7.9% CAGR DURING THE FORECASTING PERIOD 2021-2027.
Transfection is a method for injecting genetic material into mammalian cells, such as DNA or RNA. In this process, transfection reagents and equipment are used, with the reagents containing the genetic material and the equipment acting as a delivery vehicle for the genetic material. Various chemical, biological, or physical approaches may be used to insert genetic material into the desired cells. These transfection reagents techniques are used as an analytical method for smoothing out the characteristics of genetic functions, protein synthesis, cell growth, and development. This approach not only advances cellular science, but it also assists in the development of a wide range of drug strategies. Such reagents can be used in a variety of ways, including chemical, physical, and biological approaches. Technological advances in transfection, an increase in R&D spending and research activities by pharmaceutical and biotech companies, and an increase in supply for synthetic genes are all driving market growth.
Request for a sample report: Whipsmart (whipsmartmi.com)
Key Driving Factors: Advancement in Technology
Development in the field of recombinant technology and proteomics, as well as an increase in the use of transfection technology by academic researchers, are some of the main trends affecting market development. The introduction of novel reagents to extend transfection use across a wide range of applications is expected to accelerate market development. The human response to the COVID-19 pandemic is being led by biopharmaceutical innovators. Market growth is expected to be fuelled by an increase in new drug development and efforts to create more gene-based therapeutics.
This report offers the major market player’s profiles, such as Thermo Fisher Scientific Inc, PROMEGA CORPORATION, Lonza Group Ltd, Qiagen N.V, Bio–Rad Laboratories, Inc, Maxcyte, Inc, Merck KGaA, Polyplus-Transfection Sa, F. Hoffmann-La Roche Ltd, and Mirus Bio LLC
Opportunities: Globally, the number of cancer patients is increasing:
Because of the growing number of cancer patients around the world, the transfection reagent and equipment market is expected to expand significantly in the future. Cancer is the most common cause of death in the world. The use of gene therapy in new cancer treatment methods has gotten a lot of coverage. The use of transfection reagents and equipment has increased in developing countries due to early diagnosis and an increase in clinical trials. The market is also expected to be powered by targeted drug delivery using nanostructured drug delivery systems.
The market is divided into two groups based on product: reagents and equipment. In2021, reagents had the largest market share. Exogenous nucleic acids, such as DNA, RNA, or oligonucleotides, are more easily absorbed by cells when transfection reagents are used. The transfection reagents ensure that the transfection process is as efficient as possible by delivering the greatest number of transfected cells with the foreign gene. When transfecting a variety of cell types, the reagents are often poor in toxicity.
The Transfection Reagents and Equipment market report has been categorized as below
- Calcium Phosphate
- Others (Genegun, Sonoporation, Magnetofection, and Optoinjection)
- Biomedical Research
- Gene Expression Studies
- Cancer Research
- Transgenic Model
- Protein Production
- Therapeutic Delivery
By End User
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- North America
- Asia Pacific
- Rest of World
Access to Full Report Summary: Transfection Reagents and Equipment Market Research Report Global Analysis from 2021 2027
Published Date : April-2021